{"nct_id":"NCT03593200","title":"A Phase IIa Study to Assess the Safety, Efficacy, and Pharmacokinetics of Subcutaneously Administered Pegcetacoplan (APL-2) in Subjects With PNH","status":"COMPLETED","status_verified_date":"2020-12","start_date":"2018-08-16","start_date_type":"ACTUAL","primary_completion_date":"2019-10-22","primary_completion_date_type":"ACTUAL","completion_date":"2019-10-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["APLS"]}